Journal for Clinical Studies is a peer reviewed journal which details practical & theoretical operational procedures, challenges and regulatory guidelines.
WHAT SOLUTIONS DO GOVERNMENT AND OPPOSITION PARTIES HAVE FOR LONG-TERM HEALTH FUNDING AND PLANNING? The House of Lords Committee on the Long... https://t.co/4nPKoKW3Qn
https://t.co/4nPKoKW3Qn
Overcoming the Challenges of Obtaining Informed Consent During the Pandemic The COVID-19 pandemic created a public h... https://t.co/LLQfrsACly
https://t.co/LLQfrsACly
Artificial Intelligence in Life Sciences – How Far Can it Go? AI, or artificial intelligence, is one o... https://t.co/FZBSaPKDNv
https://t.co/FZBSaPKDNv
FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder
As the United States' opioid epidemic r... https://t.co/5k9A4olxDB
https://t.co/5k9A4olxDB
Innoviva subsidiary Entasis scores FDA nod for bacterial pneumonia combo drug Xacduro
In financial distress last May, AstraZe... https://t.co/mAxkaEdskE
https://t.co/mAxkaEdskE
Allergan's new skin-smoothing product gets FDA nod—with novel delivery mechanism
AbbVie'saesthetics unit is growin... https://t.co/EXOyIZOmnd
https://t.co/EXOyIZOmnd
Sandoz announces global deal to commercialize proposed biosimilar natalizumab, a key multiple sclerosis medicine
Sandoz, a Novartis division and a globa... https://t.co/3rcJB2I8Fp
https://t.co/3rcJB2I8Fp
AvKARE bottles mix Viagra generics with antidepressant, triggering recall
A generic drugmaker with a Rolodex full... https://t.co/1oYS7tQGPk
https://t.co/1oYS7tQGPk
THE PHARMACEUTICAL MANUFACTURING AND PACKAGING CONGRESS (PHARMAP 2023)
12-13, June 2023 in Geneva, Switzerland... https://t.co/mdq8bWE2u3
https://t.co/mdq8bWE2u3
With U.S. elections nearing, European pharma giants brace for potential pricing action
With U.S. presidential and congressiona... https://t.co/dap0EGEwiq
https://t.co/dap0EGEwiq
Beating its rivals, GSK nabs world-first approval for adult RSV vaccine Arexvy
In landing an FDA approval for its high... https://t.co/eTXfdNSo1J
https://t.co/eTXfdNSo1J
As Amgen's revenues slide, so too do sales at its big buyout target Horizon
As Horizon works to close its $28 billi... https://t.co/fuupKPDY3B
https://t.co/fuupKPDY3B
ImmunoGen touts 'home run' as ovarian cancer drug Elahere extends lives in landmark trial win
ImmunoGen has shaken off a previous pha... https://t.co/QtcJKww3j0
https://t.co/QtcJKww3j0